Centralization of Esophageal Cancer Surgery: Does It Improve Clinical Outcome?
Michel W.J.M. Wouters(The Netherlands Cancer Institute), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Saskia le Cessie(Leiden University Medical Center), Willem H. Steup, L. P. S. Stassen(Reinier de Graaf Hospital), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Hugo W. Tilanus(Amsterdam UMC Location University of Amsterdam), H. E. Karim-Kos(Netherlands Comprehensive Cancer Organisation)
Cited by 153
Related Papers
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
|New England Journal of Medicine|2004|1.7k
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
|New England Journal of Medicine|2017|1.4k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|795